Zocca Mai-Britt 4
4 · IO Biotech, Inc. · Filed Nov 12, 2021
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Zocca Mai-Britt
DirectorChief Executive Officer
Transactions
- Conversion
Common Stock
[F1][F2]2021-11-09+26,580→ 26,580 total(indirect: Zocca Consulting ApS) - Conversion
Class A Stock
[F1][F2]2021-11-09−26,580→ 0 total(indirect: Zocca Consulting ApS)→ Common Stock (26,580 underlying)
Holdings
- 354
Common Stock
Footnotes (2)
- [F1]Upon the closing of the Issuer's initial public offering, each share of Class A Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into the number of shares of Common Stock reported in Column 7 of Table II. These shares of Class A Stock had no expiration date.
- [F2]The reporting person is the sole owner of Zocca Consulting ApS and, in such capacity, may be deemed to beneficially own the shares held directly by Zocca Consulting ApS. The reporting person disclaims beneficial ownership of the shares held directly by Zocca Consulting ApS except to the extent of his pecuniary interest therein.
Signature
/s/ Brian Burkavage, Attorney-in-Fact for Mai-Britt Zocca|2021-11-12